http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2590691-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-707 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cc3c2b6ac638748f656865a92aff6ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7577c8ebd71078c25ce0908af7f6444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf360ba1ab8bca59f21dc8b356e2e58 |
| publicationDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2590691-C2 |
| titleOfInvention | Prediction of kinetics of hepatitis c virus in interferon-excluding treatment |
| abstract | FIELD: biotechnologies. n SUBSTANCE: invention relates to biotechnology and virology. Invention describes method for prediction of early reduction of viral load in human infected by hepatitis C virus (HCV) in response to interferon-excluding treatment, method for selection of interferon-excluding treatment duration, and method for prediction of HCV infected subject's response to interferon-excluding treatment. These methods involve detection of nucleotide in sample taken from subject, located in single-nucleotide polymorphism rs12979860 position, and interpretation of obtained results based on availability of alleles C or T in this position. n EFFECT: presented group of inventions can be applied in medicine. n 15 cl, 2 dwg, 3 tbl, 1 ex |
| priorityDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.